Vertex to Present at Cowen’s 42nd Annual Health Care Conference on March 8
March 01 2022 - 4:05PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will present at Cowen’s 42nd Annual
Health Care Conference on Tuesday, March 8, 2022 at 2:50 p.m.
ET.
A live webcast of management's remarks will be available through
Vertex's website, www.vrtx.com in the "Investors" section under the
"News and Events" page. A replay of the conference webcast will be
archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has multiple approved medicines
that treat the underlying cause of cystic fibrosis (CF) — a rare,
life-threatening genetic disease — and has several ongoing clinical
and research programs in CF. Beyond CF, Vertex has a robust
pipeline of investigational small molecule, cell and genetic
therapies in other serious diseases where it has deep insight into
causal human biology, including sickle cell disease, beta
thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes,
alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London. Additionally, the company
has research and development sites and commercial offices in North
America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 12 consecutive years on Science magazine's Top
Employers list and one of the 2021 Seramount (formerly Working
Mother Media) 100 Best Companies. For company updates and to learn
more about Vertex's history of innovation, visit www.vrtx.com or
follow us on Facebook, Twitter, LinkedIn, YouTube and
Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220301006167/en/
Vertex Pharmaceuticals Incorporated Investors: Michael
Partridge, 617-341-6108 Manisha Pai, 617-429-6891 Miroslava
Minkova, 617-341-6135
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Oct 2023 to Oct 2024